Nowadays, though, you will notice that even young women suffer from osteoporosis. Before I continue, I will ask you to think what is it that determines if our bones are healthy or not? The health of our bones, depend on the signals that are being sent to our body, and the hormonal response that follows them. When the body is exposed to some kind of external stress and I mean physical stress - caused by our daily physical activity or working out, then the body receives signals that the bones should be strong enough in order to sustain the body.
When such a stress is missing, the body receives signals that bones are not needed. As you know, number one priority for our body is survival. The same happens with our bones. What is the connection between osteoporosis and posture? Every one of us knows about gravity. It acts upon everyone of us. Few people realize exactly how gravity works- it acts in a straight perpendicular angle- i.
The reaction of the support, acts upon the person- it is less. Probably you are aware that weight is just the property of the body to participate in the gravity effect. Now, imagine our own body.
If we are standing properly- vertically in neutral position , then we are in a position where gravity acts the same way, but the weight and the reaction of the support the floor on the person is bigger. The International Osteoporosis Foundation estimates that osteoporosis affects about million women worldwide. Why the gender gap? Women start with lower bone density than their male peers and they lose bone mass more quickly as they age, which leads to osteoporosis in some women.
Between the ages of 20 and 80, the average white woman loses one-third of her hip bone density, compared to a bone density loss of only one-fourth in men. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, osteoporosis statistics show a greater burden for women in the following ways:.
Osteoporosis may have its roots in childhood and adolescence, which is the period when your body does the most bone building. Women reach their peak bone mass at about age 18 while men reach theirs at After that, both women and men continue to build small amounts of bone mass, but men add more than women.
By 30, your bones are fully stocked, and although your body will continue to replace old bone cells, there will be no increase in bone mass past that point. Add osteoporosis to the long list of health issues, like mood swings and migraines , that you can blame on your hormones. Although there are other possible genetic and environmental factors behind bone loss, your body's changing levels of estrogen remains the most culpable suspect.
Defining the role of genetic factors and their interaction with many of the environmental and hormonal determinants that have been established as potential etiologic agents responsible for low bone mineral density and fracture will certainly be the most difficult challenge facing basic and clinical researchers.
On, the other hand, the strength of data from basic and clinical studies over the last decade, now allows practitioners to confidently diagnose osteoporosis. New treatment strategies offer greater hope for patients suffering from this disease. Turn recording back on. National Center for Biotechnology Information , U.
Contents www. Search term. Rosen , MD. Author Information Clifford J. Table 1. Table 2. Etiology of Osteoporosis in Men. Table 3. Effects of Glucocorticoids on Bone Mass. These include the following: 1.
A quantifiable phenotype; 2. Heterogeneity within a given population under study; 3. The polygenic nature of the disorder; 4. Epistasis gene-gene interaction 5. Pleiotropy- phenotypic differences with identical genotypes, and 6. Gene by environmental interactions. Risk factors for hip fracture in white women. N Engl J Med. The diagnosis of osteoporosis. J Bone Min Res. Perspective: How many women have osteoporosis? Which fractures are associated with low appendicular bone mass in elderly women?
The Study of Osteoporotic Fractures. Ann Intern Med. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis Int. The variable incidence of hip fracture in southern Europe: The Medos Study. Hip fractures in the elderly: a world wide projection. Brussels; European Commission Fractures in the elderly: epidemiology and demography.
Bailliere's Clin Endocrinol Metab. Ross PD. Clinical Consequences of vertebral fractures. Am J Med. O Neill TW. Felsenberg D, Varlow J. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res. Arch Osteoporosis. Patient-reported barriers to osteoporosis therapy. Endocrinol Metab Clin North Am.
Adler RA. Curr Opin Endocrinol Diabetes Obes. Bisphosphonates and atypical femoral fractures. Whittier X, Saag KG. Rheum Dis Clin North Am. Glucocorticoid-induced Osteoporosis. Meta-analysis of how well measures on bone mineral density predict occurrence of osteoporotic fractures. Br Med J. Prediction of a second hip fracture: the potential role of DXA, ultrasound, and other risk factors for targeting of preventative therapy.
J Clin Densitometry. Risk factors for falls among elderly persons living in the community. Miller PD. Guidelines for the clinical utilization of bone mass measurements in the adult population. Calcif Tiss Int. Ann Rheum Dis. The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Changes in bone mineral density of the proximal femur and spine with ang: differences between the postmenopausal and senile osteoporosis syndromes.
J Clin Invest. In vivo assessment of trabecular bone architecture by high resolution peripheral quantitative CT. J Clin Endocrinol Metab. Martineau P, Leslie WD.
Trabecular bone score TBS : Method and applications. Transl Res. Advances in imaging approaches to fracture risk evaluation. Academic Press, San Diego pp Bonewald LF. Nat Rev Rheumatol. Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.
J Biol Chem. Modulation of osteoclast differentiation. Endocrine Rev. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. Romosozumab treatment in postmenopausal women with osteoporosis. Pharmacol Ther. Macrophages and skeletal Health. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. Increased osteoclast development after estrogen loss: mediation by IL The effect of surgical menopause and estrogen replacement on cytokine release from human blood monocytes.
Emerging insights into the pathophysiology of osteoporosis. PLoS One. Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone. Denosumab reduces cortical porosity of the proximal femoral shaft in postmenopausal women with osteoporosis.
Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med Aug 8 , Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report. Ther Adv Endocrinol Metab. The obesity of bone. Mechanisms of marrow adiposity and its implications for skeletal health. Rosen CJ. Baron R, Rawadi G. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
Sclerostin inhibition in the management of osteoporosis. Calcif Tissue Int. Expert Opin Biol Ther. Romosozumab for the treatment of osteoporosis. Albright F. Postmenopausal osteoporosis. Use of the N-telopeptide of type I collagen to monitor the effect of therapy and predict changes in bone mineral density in postmenopausal women treated with hormone replacement therapy.
Associations between low levels of serum estradiol, bone density and fractures among elderly women: SOF. Endogenous sex steroids and bone mineral density in older women and men.
Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. Aromatase deficiency in male and female siblings caused by a novel mutation in the physiological role of estrogens. Carani C, Qin K.
Effect of testosterone and estradiol in a man with aromatase deficiency. Effect of testosterone treatment on body composition and muscle strength in men over J Clin Endo Metab. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: A Randomized Placebo-Controlled Trial.
Elderly women in northern new England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner. The report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. Dietary Changes favorably affect bone remodeling in older adults.
Cushing H. Basophile adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hop. Thacker H. Cleveland Clinic J Med 77 Teegarden D, Proulx WR. Peak bone mass in young women.
Spinal bone loss and ovulatory disturbances. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Gender differences in vertebral size in adults: biomechanical implications.
Decreased bone density in adolescent girls with anorexia nervosa. Calcium supplementation and increases in bone mineral density in children. IGF-I a unique calcium dependent stimulator of 1,25 vitamin D production. Diabetes and Bone Disease. Type 2 diabetes and the skeleton: new insights into sweet bones. Lancet Diabetes Endocrinol. Familial comparison of bone mineral density at the proximal femur and lumbar spine.
Genetic factors in determining bone mass. Seeman E. Beyond one gene-one disease: Alternative strategies for deciphering genetic determinants of osteoporosis. Relation of alleles of the collagen type I alpha 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. Nat Rev Genet. Genetics of osteoporosis from genome-wide association studies: advances and challenges. High bone density due to mutation in LDL-receptor related protein New Engl J Med.
Am J Hum Genet. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q Calcium enriched foods and bone mass growth in prepubertal girls: a randomized double blind placebo controlled trial. A longitudinal study of bone gain in pubertal girls: anthropometric and biochemical correlates. Adolescent nutrition in the prevention of postmenopausal osteoporosis. Bonjour JP, Chevalley T.
Endocr Rev. Pubertal timing, bone acquisition, and risk of fracture throughout life. Postmenopausal Osteoporosis. The Epidemiology and Pathogenesis of Osteoporosis. In this Page. Links to www. View this chapter in Endotext. Related information. Similar articles in PubMed. Medical Advisory Secretariat.. Ont Health Technol Assess Ser.
Epub Nov 1. Review Unresolved issues in osteoporosis in men. Rev Endocr Metab Disord. Review Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
0コメント